-
Recent Posts
- Can Raptor Pharmaceutical Corp. (NASDAQ: RPTP) Turn FDA Approval into Big Payday Down the Road?
- Camtek Ltd. (NASDAQ: CAMT) Shares Climb After First Quarter Growth and Positive Outlook
- Is There Hope for Next Generation Corp. (OTCQB: NGMC) in Oil and Gas Industry?
- Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Spikes with Promise of Tasimelteon
- Is Enviro-Serv, Inc. (PINKSHEETS: EVSV) Any Closer to Generating Revenues?
Categories
OTC Equity Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tags
aapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods cloud computing copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare stocks investors ipad iphone mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical pinksheets Pink Sheets s silver sprint stocks tradingSite
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: pfizer
Investors Taking Notice of Potential in Acura Pharmaceuticals, Inc. (NASDAQ: ACUR)
After closing Wednesday’s trading session at 1.42 on light volume shares of Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) have spiked considerably on Thursday, climbing as high as 2.60 with more than 1 million shares exchanging hands by early afternoon. That 2.60 … Continue reading
Posted in Articles, NASDAQ
Tagged acur, acura pharmaceuticals, fda, investors, medication abuse, oxycodone, pfizer, pharmaceutical
Leave a comment
Can Pain Therapeutics Inc. (NASDAQ: PTIE) Overcome Setback Related to Remoxy?
Shares of Pain Therapeutics Inc. (NASDAQ: PTIE) continue to take a beating following news that their lead drug candidate Remoxy will be subjected to further tests before Pfizer agrees to seek FDA approval for the pain medication. Just yesterday shares … Continue reading
Posted in Articles, NASDAQ
Tagged biopharmaceutical, fda, investors, oxycodone, pain medication, pain therapeutics, pfizer, ptie, remoxy
Leave a comment
Investors Interested in United Management Group, Inc.(PINKSHEETS: UYMG) Have More Questions than Answers
It doesn’t take a lot of digging before investors uncover a number of questions concerning the operations of Unity Management Group, Inc. (PINKSHEETS: UYMG). While the company announced on Wednesday that their subsidiary, Metropolitan Computing Corporation (MCC), had sold its … Continue reading
Posted in Uncategorized
Tagged amgen, bristol meyers, investors, penny stocks, pfizer, pharmaceutical, pinksheets, teva, united management, uymg
Leave a comment
Alexza Pharmaceuticals (NASDAQ: ALXA) Gaining Momentum on FDA Approval Recommendation Regarding ADASUVE
Following news that Alexza Pharmaceuticals (NASDAQ: ALXA) received recommendation for FDA approval from the Psychopharmacologic Drugs Advisory Committee (PDAC) of the U.S. Food and Drug Administration (FDA) relating to their schizophrenia and bipolar mania treatment ADASUVE shares in the pharmaceutical … Continue reading
Posted in Articles, NASDAQ
Tagged adasuve, alexza pharmaceuticals, alxa, bristol-myers, eli lilly, fda, fda approval, investors, NASDAQ, pfizer, staccato
Leave a comment
Icagen, Inc. (NASDAQ: ICGN) Could See Bad Memories Erased with Pfizer, Inc. (NYSE: PFE) “Strategic Transaction”
Nine months ago Icagen, Inc. (NASDAQ: ICGN) announced they had completed a one-for-eight reverse stock split that managed to push shares from 0.13 to 1.01 and put them back in compliance with NASDAQ listing requirements. Times have changed significantly for … Continue reading
Posted in Articles, NASDAQ, Penny Stocks
Tagged biopharmaceutical, drug maker, fda, icagen, invstors, merger, NASDAQ, nyse, penny stocks, pfe, pfizer, remoxy
Leave a comment
NYSE Companies Hitting New 52-Week Highs on Monday: PFE, TSO, LZ, STD, POT
A number of companies trading on the NYSE managed to set new 52-week highs on Monday including Pfizer (PFE), Tesoro Petroleum Corp (TSO), Lubrizol Corp. (LZ), Banco Santander S.A. (STD), and Potash Corporation (POT).
Despite Milestone Payment from Pfizer Future for Icagen, Inc. Remains Uncertain
News of a $1 million milestone payment from Pfizer (NYSE: PFE) earlier this week sent shares in Icagen, Inc. (NASDAQ: ICGN) skyrocketing to a 52-week high of 2.63 but the push north quickly halted and before long shares tumbled below … Continue reading
Posted in Articles, NASDAQ
Tagged asthma, epilepsy, icagen, icgn, investors, NASDAQ, nyse, pain managementfda, penny stocks, pfe, pfizer
Leave a comment
Healthcare Stocks Showing Signs of Life: ICGN, APCVZ, RPRX, SCR, BASI
While Healthcare Stocks took a hit on Tuesday, dropping 0.97%, there were several companies that proved to have plenty of life with Icagen, Inc. (NASDAQ: ICGN) earning the top grade as shares jumped 78.69% on the day to close at … Continue reading
Posted in NASDAQ, News
Tagged apcvz, basi, bioanalytical systems, biopharmaceutical, fda, healthcare stocks, icagen, icgn, investors, NASDAQ, nyse, penny stocks, pfizer, repros, rprx, scr, simcere pharmaceutical
Leave a comment


